Our in silico RNA-seq data analyses of human normal and malignant skin corroborate the presence of the identified molecular mechanism of a HH/GLI-dependent IDO1 induction in melanoma and non-melanoma skin cancer patients. This evidence concerns the gene GLI1 and melanoma.